CA Stock MarketDetailed Quotes
MYND MYND Life Sciences Inc
- 0.040
- 0.0000.00%
15min DelayMarket Closed Jul 16 15:58 ET
1.91MMarket Cap-4000P/E (TTM)
0.000High0.000Low0Volume0.000Open0.040Pre Close0.00Turnover0.10052wk High0.00%Turnover Ratio47.82MShares0.00552wk Low-0.01EPS TTM1.33MFloat Cap2.500Historical HighLossP/E (Static)33.24MShs Float0.005Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM-0.34P/B1Lot Size--Div YieldTTM
MYND Life Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | (Q3)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 239.63%39.82K | -376.57%-38.32K | 89.10%-198.26K | -474.15%-173.02K | -3,272.35%-50.82K | 108.88%11.72K | 100.80%13.86K | 38.99%-1.82M | 104.13%46.24K | 100.23%1.6K |
| Net income from continuing operations | 57.97%-259.56K | 55.54%-372.76K | 57.45%-1.52M | 184.83%469.04K | 37.14%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.32%-3.57M | 63.86%-552.88K | 2.77%-844.44K |
| Operating gains losses | ---- | ---- | -6,773.68%-999.3K | ---- | ---- | ---- | ---- | ---14.54K | ---- | ---- |
| Depreciation and amortization | -91.70%652 | -94.23%654 | -64.92%20.99K | -92.33%892 | -92.34%891 | -47.46%7.86K | -47.53%11.34K | -30.53%59.83K | -27.35%11.63K | 20.72%11.63K |
| Remuneration paid in stock | --0 | --0 | -77.81%22.88K | 114.58%22.88K | --0 | --0 | --0 | -91.13%103.11K | -140.71%-156.89K | -247.24%-50.63K |
| Deferred tax | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 22.79%-129.95K | ---- | ---- |
| Other non cashItems | ---- | ---- | 2.94%525.85K | -248.92%-64.19K | 27.85%216.36K | 24.02%223.46K | 26.97%150.22K | -1.27%510.82K | -91.42%43.11K | --169.22K |
| Change In working capital | -44.21%222.06K | -51.68%333.79K | 43.54%1.75M | -52.98%397.66K | -63.30%262.71K | -25.18%398.02K | 178.95%690.79K | 672.03%1.22M | 360.52%845.77K | 608.81%715.82K |
| -Change in receivables | -185.92%-103.43K | 207.81%15.25K | 514.33%127.39K | 24.87%5.74K | 219.74%15.42K | 707.26%120.38K | -436.07%-14.15K | 68.52%-30.75K | -93.55%4.6K | 66.81%-12.88K |
| -Change in prepaid assets | -81.26%-8.64K | -90.44%10.3K | 706.67%397.11K | 0.57%296.27K | -100.72%-2.15K | -101.44%-4.76K | 110.91%107.75K | 81.00%-65.46K | 257.80%294.6K | 3,077.20%297.75K |
| -Change in payables and accrued expense | 18.31%334.13K | -48.39%308.23K | -6.85%1.22M | -82.50%95.65K | -42.12%249.44K | 27.30%282.41K | 417.38%597.19K | 473.70%1.31M | 361.31%546.57K | 187.69%430.95K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 239.63%39.82K | -376.57%-38.32K | 89.10%-198.26K | -474.15%-173.02K | -3,272.35%-50.82K | 108.88%11.72K | 100.80%13.86K | 38.99%-1.82M | 104.13%46.24K | 100.23%1.6K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 100.57%57 | 0 | 347.63%198.1K | 771.14%223.1K | 0 | 35.53%-10K | 7.68%-15K | -103.76%-80K | -113.11%-33.24K | 90.11%-15K |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| Net business purchase and sale | ---- | ---- | --223.1K | --223.1K | ---- | ---- | ---- | --0 | --0 | ---- |
| Net other investing changes | ---- | ---- | 68.75%-25K | --0 | --0 | 50.00%-10K | 50.00%-15K | 24.17%-80K | -105.73%-15K | 13.78%-15K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 100.57%57 | --0 | 347.63%198.1K | 771.14%223.1K | --0 | 35.53%-10K | 7.68%-15K | -103.76%-80K | -113.11%-33.24K | 90.11%-15K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 50K | 0 | 0 | 0 | ||||
| Net issuance payments of debt | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| Net common stock issuance | --0 | --0 | ---- | ---- | --50K | --0 | --0 | ---- | ---- | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | ---- | ---- | --50K | --0 | --0 | ---- | ---- | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -5,107.66%-38.07K | -37.86%256 | -99.98%412 | 119.48%172 | -92.07%993 | -100.46%-731 | -99.98%412 | --1.9M | -100.75%-883 | -98.72%12.52K |
| Current changes in cash | 2,212.94%39.88K | -3,252.93%-38.32K | 99.99%-155 | -93.44%85 | 93.87%-821 | 101.17%1.72K | 99.93%-1.14K | -199.98%-1.9M | -99.93%1.3K | 98.44%-13.4K |
| End cash Position | 81.97%1.81K | -5,107.66%-38.07K | -37.62%257 | -37.62%257 | 119.48%172 | -92.07%993 | -100.46%-731 | -99.98%412 | -99.98%412 | -100.75%-883 |
| Free cash from | 228.49%38.51K | -376.57%-38.32K | 89.10%-198.26K | -474.15%-173.02K | -3,272.35%-50.82K | 108.88%11.72K | 100.80%13.86K | 39.88%-1.82M | 104.66%46.24K | 100.19%1.6K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg